Email Updates

You are here

Partner Services Pre-exposure Prophylaxis (PS-PrEP)

Phase
Open Label
Principal Investigator(s)
John Schnedier, MD
Objective

This study evaluates the feasibility (reach, adoption, safety and implementation) and initial efficacy (higher linkage to care) of the Partner Services Pre-exposure Prophylaxis (PS-PrEP) intervention versus phone based Pre-exposure Prophylaxis (PrEP) treatment at 3 months post randomization among a sample of high risk individuals 18 - 35 years from clinic-based recruitment and internal referrals from social network based projects. The evaluation of the intervention will be used to strengthen routine department of public health services linkage to PrEP care.

Prevention Option(s)
PrEP
Study Design
Randomized
Open label
Trial Sponsors
University of Chicago
November 2015
December 2019
Enrollment
120
18
Years
35
Years
Population
Men
Sites

University of Chicago Medical Center

Chicago, Illinois
United States of America